Literature DB >> 3131487

The absence of interferon antibody formation in patients receiving recombinant human interferon-gamma.

H S Jaffe1, A B Chen, S Kramer, S A Sherwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3131487

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN： 0732-6580


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and biological activity in subcutaneous long-term administration of recombinant interferon-gamma in cancer patients.

Authors:  W Digel; G Zahn; G Heinzel; F Porzsolt
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 2.  Clinical toxicity of the interferons.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1994-02       Impact factor: 5.606

Review 3.  Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma.

Authors:  David A Braun; Ziad Bakouny; Laure Hirsch; Ronan Flippot; Eliezer M Van Allen; Catherine J Wu; Toni K Choueiri
Journal:  Nat Rev Clin Oncol       Date:  2021-01-12       Impact factor: 66.675

Review 4.  Safety, Tolerability, and Immunogenicity of Interferons.

Authors:  Michael G Tovey; Christophe Lallemand
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.